Prognostic and predictive value of p53 and p21 in breast cancer
- 1 November 1998
- journal article
- review article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 52 (1-3), 79-98
- https://doi.org/10.1023/a:1006163101948
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survivalBritish Journal of Cancer, 1996
- p53 protein as a prognostic indicator in breast carcinoma: a comparison of four antibodies for immunohistochemistryBritish Journal of Cancer, 1996
- p53 as a prognostic factor in stage I breast cancerBritish Journal of Cancer, 1995
- Prognostic significance of p53 overexpression in primary breast cancer; a novel luminometric immunoassay applicable on steroid receptor cytosolsBritish Journal of Cancer, 1995
- Prognostic significance of TP53 alterations in breast carcinomaBritish Journal of Cancer, 1993
- Association of p53 Protein Expression With Tumor Cell Proliferation Rate and Clinical Outcome in Node-Negative Breast CancerJNCI Journal of the National Cancer Institute, 1993
- p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptorBritish Journal of Cancer, 1992
- Association of Overexpression of Tumor Suppressor Protien p53 With Rapid Cell Proliferation and Poor Prognosis in Node-Negative Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1992
- Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast CancersJNCI Journal of the National Cancer Institute, 1992
- Nuclear p53 Immunoreaction Associated with Poor Prognosis of Breast CancerJapanese Journal of Cancer Research, 1991